Product Information

YUSIMRY(CF) 40 MG/0.8 ML PEN is a brand biologic product labeled by Meitheal Pharmaceuticals Inc., priced at $602.9450 per ML under NDC 71288081581. Its NADAC has been published 30 times since Oct 29, 2025.

YUSIMRY(CF) 40 MG/0.8 ML PEN

adalimumab-aqvh
$602.9450per ML

Strength

40 mg/.8mL

NDC

71288081581

Classification

Brand Biologic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

ADALIMUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761216

On Market Since

7/1/2023

Pharmacological Classes

Antibodies
Monoclonal
Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity

Price Statistics

The NADAC for YUSIMRY(CF) 40 MG/0.8 ML PEN has been published 30 times since Oct 29, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$602.9450 per ML
All-time high$604.1525 (May 13, 2026)
All-time low$602.9450 (Nov 18, 2026)
52-week high$604.1525
52-week low$602.9450
Median price$604.1525
Average price$604.1123
Largest weekly change-0.2% (Nov 18, 2026)
Weeks tracked30
Tracking sinceOct 29, 2025

Price History

1W

-0.2%

1M

-0.2%

3M

-0.2%

6M

-0.2%

1Y

-0.2%

3Y

N/A

5Y

N/A

All

-0.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of YUSIMRY(CF) 40 MG/0.8 ML PEN?

The current National Average Drug Acquisition Cost (NADAC) for YUSIMRY(CF) 40 MG/0.8 ML PEN, manufactured by Meitheal Pharmaceuticals Inc., is $602.9450 per ML (NDC 71288081581), effective Nov 18, 2026.

How has the price of YUSIMRY(CF) 40 MG/0.8 ML PEN changed over time?

Over the history we have for it, the NADAC for YUSIMRY(CF) 40 MG/0.8 ML PEN has held within roughly two percent of its current level. It has been tracked across 30 weekly CMS publications since Oct 29, 2025.

What are the highest and lowest recorded NADAC prices for YUSIMRY(CF) 40 MG/0.8 ML PEN?

Since Oct 29, 2025, the NADAC for YUSIMRY(CF) 40 MG/0.8 ML PEN has ranged from a low of $602.9450 (Nov 18, 2026) to a high of $604.1525 (May 13, 2026), with a median of $604.1525 per ML.

Are there cheaper alternatives to YUSIMRY(CF) 40 MG/0.8 ML PEN?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as YUSIMRY(CF) 40 MG/0.8 ML PEN in a comparable dosage form, but none are currently priced below it.

Who manufactures YUSIMRY(CF) 40 MG/0.8 ML PEN?

YUSIMRY(CF) 40 MG/0.8 ML PEN (NDC 71288081581) is labeled by Meitheal Pharmaceuticals Inc., and CMS classifies it as a brand biologic product.